Glucocorticoid receptor binding to chromatin is selectively controlled by the coregulator Hic-5 and chromatin remodeling enzymes.

Brian H. Lee, Lee BH, Michael R. Stallcup, Stallcup MR
Journal of Biological Chemistry · 2017 · doi:10.1074/jbc.m117.782607 · PMID:28381557 · PMC5454112
OA: closed CC-BY-4.0
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-07, 2026-07-17 ⓘ

The coregulator Hic-5 selectively blocks glucocorticoid receptor binding to specific gene regulatory regions by inhibiting its interaction with chromatin remodeling enzymes CHD9 and BRM.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The steroid hormone-activated glucocorticoid receptor (GR) regulates cellular stress pathways by binding to genomic regulatory elements of target genes and recruiting coregulator proteins to remodel chromatin and regulate transcription complex assembly. The coregulator hydrogen peroxide-inducible clone 5 (Hic-5) is required for glucocorticoid (GC) regulation of some genes but not others and blocks the regulation of a third gene set by inhibiting GR binding. How Hic-5 exerts these gene-specific effects and specifically how it blocks GR binding to some genes but not others is unclear. Here we show that site-specific blocking of GR binding is due to gene-specific requirements for ATP-dependent chromatin remodeling enzymes. By depletion of 11 different chromatin remodelers, we found that ATPases chromodomain helicase DNA-binding protein 9 (CHD9) and Brahma homologue (BRM, a product of the SMARCA2 gene) are required for GC-regulated expression of the blocked genes but not for other GC-regulated genes. Furthermore, CHD9 and BRM were required for GR occupancy and chromatin remodeling at GR-binding regions associated with blocked genes but not at GR-binding regions associated with other GC-regulated genes. Hic-5 selectively inhibits GR interaction with CHD9 and BRM, thereby blocking chromatin remodeling and robust GR binding at GR-binding sites associated with blocked genes. Thus, Hic-5 regulates GR binding site selection by a novel mechanism, exploiting gene-specific requirements for chromatin remodeling enzymes to selectively influence DNA occupancy and gene regulation by a transcription factor.

My notes (saved in your browser only)

Funding

funders
[{'doi': '10.13039/100000054', 'name': 'National Cancer Institute', 'awards': ['P30CA014089']}, {'doi': '10.13039/100000062', 'name': 'National Institute of Diabetes and Digestive and Kidney Diseases', 'awards': ['R37DK055274']}, {'doi': '10.13039/100000062', 'name': 'National Institute of Diabetes and Digestive and Kidney Diseases', 'awards': ['R01DK043093']}]

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

References (62)

Source provenance

crossref
last seen: 2026-05-23T01:00:13.797536+00:00
europepmc
last seen: 2026-08-07T06:07:27.085738+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0